Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Difficult asthma].

Pascal Chanez1, Isabelle Vachier, Arnaud Bourdin

  • 1Clinique des maladies respiratoires, CHU, Montpellier (34). chanez@montp.inserm.fr

Presse Medicale (Paris, France : 1983)
|October 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Switching Biologics in Severe Asthma: Cautionary Lessons from NIMBLE.

American journal of respiratory and critical care medicine·2026
Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same author

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

The journal of allergy and clinical immunology. Global·2026
Same author

Educational Intervention on Environmentally Responsible Inhaler Prescribing Among French General Practitioners: Pilot Pre-Post Study.

JMIR formative research·2026
Same author

Complex interplay between disease and aerobic exercise training on vascular function in an exacerbated emphysema rat model.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Reply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.

American journal of respiratory and critical care medicine·2026
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Difficult asthma requires careful diagnosis and management, considering adherence and comorbidities. Severe asthma necessitates deeper understanding of pathophysiology for targeted, innovative treatments.

Area of Science:

  • Pulmonary Medicine
  • Asthma Research

Context:

  • Difficult asthma poses significant patient and societal costs.
  • Uncontrolled asthma despite specialist care requires reevaluation of diagnosis and adherence.
  • Severe asthma persists even with optimal management, diagnosis, and controlled comorbidities.

Purpose:

  • To emphasize the need for thorough patient assessment in difficult asthma cases.
  • To highlight the importance of objective testing of standard asthma therapies.
  • To underscore the necessity of understanding severe asthma pathophysiology and phenotypes for treatment innovation.

Summary:

  • Reassess difficult asthma diagnoses, focusing on adherence, comorbidities, and objective therapy trials.
  • Severe asthma requires deeper pathophysiological insight and phenotype-specific treatment development.

Related Experiment Videos

  • A year-long patient evaluation is recommended for optimal management and objective therapy assessment.

    • Impact:

    • Improved understanding of severe asthma pathophysiology can lead to novel, targeted therapies.
    • Phenotype-specific treatments promise more rational and effective clinical applications.
    • Addressing difficult asthma comprehensively can reduce patient and societal burdens.